State governments use a system of open formularies known as preferred drug lists in Medicaid and other programs that purchase pharmaceuticals in order to control costs. The safety, efficacy, and cost effectiveness of new treatments are compared to existing ones, and the best drugs are included in the PDL. Federal trade policy seeks to limit this type of evidence-based pricing.
Trade, Policy and IP
February 26 5:00PM-6:00PM Y402 Loyola Patent Law Interview Program Workshop February 26 5:00PM-6:00PM Yuma Building - Y402 Loyola Patent Law Interview Program Workshop February 27 4:30PM-5:30PM Y402 SCOTUS Series:United States v. Microsoft Corp. March 07 12:00PM-1:00PM Yuma Building - Y115 Soundbreaking: A Discussion with Eric Schwartz (WCL ’84) March 15 12:00PM-5:00PM Yuma Building - YT01-01 Eighth Annual Patent Administrative Law Conference March 15 1:00PM-5:00PM Claudio Grossman Hall Eighth Annual Patent Administrative Law Conference March 19 5:30PM-7:30PM Yuma Building - YT01-01 Public Performance Rights in the Age of Internet Streaming: A Discussion of Spanski Enterprises, Inc. v. Telewizja Polska, S.A. April 04 12:00PM-1:00PM Yuma Building - Y403 Intellectual Property & International Trade Resources Talk April 16 5:00PM-6:00PM Yuma Building - Y402 Intellectual Property and Antitrust Law Resources Talk